graphic
News > Companies
Lilly has new Prozac type
March 14, 2000: 11:17 a.m. ET

Drug maker seeks FDA approval of once-a-week version of antidepressant
graphic
graphic graphic
graphic
NEW YORK (CNNfn) - Eli Lilly & Co., which has seen declining sales of its best-selling drug Prozac amid increased competition, asked federal regulators Tuesday to approve a once-a-week version of the popular antidepressant.
    If approved by the Food and Drug Administration, the new formula would be the only antidepressant on the market that could be taken weekly, instead of daily.
    Prozac went on the market in 1988, and since has been approved in the U.S. for treatment of obsessive-compulsive disorder and bulimia.
    Competing products include Zoloft, made by Pfizer Inc. (PFE: Research, Estimates), and Celexa, co-marketed by Forest Laboratories (FRX: Research, Estimates) and Warner-Lambert Co. (WLA: Research, Estimates).
    Shares of Indianapolis-based Eli Lilly (LLY: Research, Estimates) slipped 1-1/8 to 58-1/8 in morning trading, amid a sluggish day for pharmaceutical stocks. Back to top

  RELATED STORIES

Eli Lilly meets 4Q forecast - Jan. 27, 2000

  RELATED SITES

Eli Lilly


Note: Pages will open in a new browser window
External sites are not endorsed by CNNmoney




graphic


Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.